Hint mode is switched on Switch off

Connect Biopharma Holdings, American depositary receipt (ADR)
CNTB, US2075231017

Add a stock to WL
Connect Biopharma Holdings, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Issuer

Profile
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation.
  • Issuer
  • Full borrower / issuer name
    Connect Biopharma Holdings Ltd
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CNTB
  • Placement
    19.03.2021
  • Lock up period
    180
  • Number of papers
    11,250,000
  • Volume of raised funds
    191.25 mln USD
  • Placement share
    100%
  • Final placement price
    17 USD
  • Price change since placement date
    -100%
  • By capitalization
    191.25 mln USD

IFRS/US GAAP reports

2026
2025
2024
2023
2022
2021
Show all Hide
Registration is required to get access.